Oregon Therapeutics

Unspecified (Unknown)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

Sep 19 - Sep 23

Protein Disulfide Isomerase Inhibition: A Novel Therapeutic Strategy against Pancreatic Cancer

MRC award to University of Birmingham

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}